rawfin.tv
Cellectis Reports Q2 EPS Beat, Revenue Misses Estimates
EarningsstocksAI Generated

Cellectis Reports Q2 EPS Beat, Revenue Misses Estimates

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Cellectis reported a Q2 EPS of $-0.220, surpassing analyst estimates by $0.04. However, the company's revenue for the quarter came in at $6.9 million, falling short of market expectations.

CellectisEarningsBiotechQ22026FinancialResults

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks